Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.234ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.234ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.234EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.234EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.234ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.234ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.231EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.231EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.231ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.231ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.231EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.231EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.231ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.231ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.243EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.243EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.243ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.243ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.243EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.243EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.243ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.243ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.517EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.517EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.517ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.517ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.517EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.517EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.517ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.517ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.16.1 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.16.1 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.16.1 (Delta)ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AY.16.1 (Delta)ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AY.16.1 (Delta)EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AY.16.1 (Delta)EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AY.16.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.16.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.9.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.9.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.9.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.9.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.2.9.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.2.9.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.2.9.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.9.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.72EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.2.72EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.72ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.2.72ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used